# Expansion Study of ALT001 in Patients With Multiple System Atrophy

> **NCT07476352** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **yilong Wang** · enrollment: 60 (estimated)

## Conditions studied

- Multiple System Atrophy

## Interventions

- **DRUG:** ALT001

## Key facts

- **NCT ID:** NCT07476352
- **Lead sponsor:** yilong Wang
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-06
- **Primary completion:** 2027-10-30
- **Final completion:** 2027-10-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07476352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07476352, "Expansion Study of ALT001 in Patients With Multiple System Atrophy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07476352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*